Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats.
During the heat treatment of protein-containing foods, the amino acid lysine is most prone to undergo chemical reactions in the course of amino acid cross-linking or Maillard reactions. Among the reaction products formed, lysinoalanine (LAL), N(epsilon)-fructoselysine (FL) and N(epsilon)-carboxymethyllysine (CML) are those which serve as sensitive markers for the heat treatment applied. From a nutritional perspective, these compounds are ingested with the diet in considerable amounts but information about their metabolic transit and putative in vivo effects is scarce. In the present study, casein-linked LAL, FL and CML were administered to rats in two different doses for 10 days. Quantitation of LAL, FL and CML in plasma, tissue and faeces samples revealed that the kidneys are the predominant sites of accumulation and excretion. The maximum percent of dietary LAL, FL and CML excreted in the urine was 5.6, 5.2 and 29%, whereas the respective recoveries in the kidneys were 0.02, 26 and 1.4%. The plasma and tissue analyses revealed that the endogenous load of either compound is increased by its dietary intake. But the dose-dependent utilisation of dietary protein-linked LAL, FL and CML in rats has been demonstrated for the first time to vary substantially from each other.
Somoza
Veronika
V
German Research Centre for Food Chemistry, Garching, Germany. veronika.somoza@lrz.tum.de
Wenzel
Elisabeth
E
Weiss
Carola
C
Clawin-Rädecker
Ingrid
I
Grübel
Nadine
N
Erbersdobler
Helmut F
HF
D000818:Animals; D002364:Caseins / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry*; D004032:Diet; D004305:Dose-Response Relationship, Drug; D005243:Feces / Q000737:chemistry; D006358:Hot Temperature; D007668:Kidney / Q000737:chemistry; D008099:Liver / Q000737:chemistry; D008239:Lysine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000032:analysis / Q000493:pharmacokinetics; D008241:Lysinoalanine / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D015416:Maillard Reaction; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D002364:Caseins; D008241:Lysinoalanine; C033186:fructosyl-lysine; C048496:N(6)-carboxymethyllysine; D008239:Lysine